221 related articles for article (PubMed ID: 30939045)
1. Rare Protein-Truncating Variants in APOB, Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease.
Peloso GM; Nomura A; Khera AV; Chaffin M; Won HH; Ardissino D; Danesh J; Schunkert H; Wilson JG; Samani N; Erdmann J; McPherson R; Watkins H; Saleheen D; McCarthy S; Teslovich TM; Leader JB; Lester Kirchner H; Marrugat J; Nohara A; Kawashiri MA; Tada H; Dewey FE; Carey DJ; Baras A; Kathiresan S
Circ Genom Precis Med; 2019 May; 12(5):e002376. PubMed ID: 30939045
[TBL] [Abstract][Full Text] [Related]
2. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
[TBL] [Abstract][Full Text] [Related]
3. Association of Rare Protein-Truncating DNA Variants in APOB or PCSK9 With Low-density Lipoprotein Cholesterol Level and Risk of Coronary Heart Disease.
Dron JS; Patel AP; Zhang Y; Jurgens SJ; Maamari DJ; Wang M; Boerwinkle E; Morrison AC; de Vries PS; Fornage M; Hou L; Lloyd-Jones DM; Psaty BM; Tracy RP; Bis JC; Vasan RS; Levy D; Heard-Costa N; Rich SS; Guo X; Taylor KD; Gibbs RA; Rotter JI; Willer CJ; Oelsner EC; Moran AE; Peloso GM; Natarajan P; Khera AV
JAMA Cardiol; 2023 Mar; 8(3):258-267. PubMed ID: 36723951
[TBL] [Abstract][Full Text] [Related]
4. Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease.
Nomura A; Won HH; Khera AV; Takeuchi F; Ito K; McCarthy S; Emdin CA; Klarin D; Natarajan P; Zekavat SM; Gupta N; Peloso GM; Borecki IB; Teslovich TM; Asselta R; Duga S; Merlini PA; Correa A; Kessler T; Wilson JG; Bown MJ; Hall AS; Braund PS; Carey DJ; Murray MF; Kirchner HL; Leader JB; Lavage DR; Manus JN; Hartze DN; Samani NJ; Schunkert H; Marrugat J; Elosua R; McPherson R; Farrall M; Watkins H; Juang JJ; Hsiung CA; Lin SY; Wang JS; Tada H; Kawashiri MA; Inazu A; Yamagishi M; Katsuya T; Nakashima E; Nakatochi M; Yamamoto K; Yokota M; Momozawa Y; Rotter JI; Lander ES; Rader DJ; Danesh J; Ardissino D; Gabriel S; Willer CJ; Abecasis GR; Saleheen D; Kubo M; Kato N; Ida Chen YD; Dewey FE; Kathiresan S
Circ Res; 2017 Jun; 121(1):81-88. PubMed ID: 28506971
[TBL] [Abstract][Full Text] [Related]
5. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
[TBL] [Abstract][Full Text] [Related]
6. Protective lipid-lowering variants in healthy older individuals without coronary heart disease.
Lacaze P; Riaz M; Sebra R; Hooper AJ; Pang J; Tiller J; Polekhina G; Tonkin A; Reid C; Zoungas S; Murray AM; Nicholls S; Watts G; Schadt E; McNeil JJ
Open Heart; 2021 Jul; 8(2):. PubMed ID: 34341098
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
[TBL] [Abstract][Full Text] [Related]
8. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.
Ballantyne CM; Raichlen JS; Cain VA
J Am Coll Cardiol; 2008 Aug; 52(8):626-32. PubMed ID: 18702965
[TBL] [Abstract][Full Text] [Related]
9. Association of apolipoprotein B gene variants with plasma apoB and low density lipoprotein (LDL) cholesterol levels.
Deeb SS; Failor RA; Brown BG; Brunzell JD; Albers JJ; Motulsky AG; Wijsman E
Hum Genet; 1992 Feb; 88(4):463-70. PubMed ID: 1346774
[TBL] [Abstract][Full Text] [Related]
10. Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease.
Vega GL; Grundy SM
J Lipid Res; 1984 Jun; 25(6):580-92. PubMed ID: 6747462
[TBL] [Abstract][Full Text] [Related]
11. Serum triglyceride, high-density lipoprotein cholesterol, apolipoprotein B, and coronary heart disease in a Chinese population undergoing coronary angiography.
Ling Y; Jiang J; Wu B; Gao X
J Clin Lipidol; 2017; 11(3):646-656. PubMed ID: 28506386
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study.
Björnson E; Adiels M; Taskinen MR; Burgess S; Rawshani A; Borén J; Packard CJ
Eur Heart J; 2023 Oct; 44(39):4186-4195. PubMed ID: 37358553
[TBL] [Abstract][Full Text] [Related]
13. Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.
Conca P; Pileggi S; Simonelli S; Boer E; Boscutti G; Magnolo L; Tarugi P; Penco S; Franceschini G; Calabresi L; Gomaraschi M
J Clin Lipidol; 2012; 6(3):244-50. PubMed ID: 22658148
[TBL] [Abstract][Full Text] [Related]
14. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.
Schaefer EJ; Lamon-Fava S; Cohn SD; Schaefer MM; Ordovas JM; Castelli WP; Wilson PW
J Lipid Res; 1994 May; 35(5):779-92. PubMed ID: 8071601
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
[TBL] [Abstract][Full Text] [Related]
16. In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene.
Elias N; Patterson BW; Schonfeld G
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1309-15. PubMed ID: 10807747
[TBL] [Abstract][Full Text] [Related]
17. Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study.
Heiba IM; DeMeester CA; Xia YR; Diep A; George VT; Amos CI; Srinivasan SR; Berenson GS; Elston RC; Lusis AJ
Am J Med Genet; 1993 Nov; 47(6):875-83. PubMed ID: 8279486
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
Hooper AJ; Heeks L; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PH; van Bockxmeer FM; Burnett JR
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
[TBL] [Abstract][Full Text] [Related]
19. Two apolipoprotein B gene defects in a kindred with hypobetalipoproteinemia, one of which results in a truncated variant, apoB-61, in VLDL and LDL.
Pullinger CR; Hillas E; Hardman DA; Chen GC; Naya-Vigne JM; Iwasa JA; Hamilton RL; Lalouel JM; Williams RR; Kane JP
J Lipid Res; 1992 May; 33(5):699-710. PubMed ID: 1619363
[TBL] [Abstract][Full Text] [Related]
20. Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.
Wingo TS; Cutler DJ; Wingo AP; Le NA; Rabinovici GD; Miller BL; Lah JJ; Levey AI
JAMA Neurol; 2019 Jul; 76(7):809-817. PubMed ID: 31135820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
